Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Group is seeking to appoint an outstanding, skilled and ambitious Research Assistant to contribute to a programme of basic and translational research focussed on the development of clinical stem cell
-
backgrounds with a rigorous understanding of artificial intelligence and its societal, ethical, and theoretical foundations. The postholder will play a central role in the design, development, and delivery
-
& Metabolic Medicine & Sciences (SCMMS) provides an outstanding multi-disciplinary environment for the pursuit of cutting-edge cardiovascular and metabolic research (https://www.kcl.ac.uk/scmms ). We study the
-
King's, please visit https://www.kcl.ac.uk/informatics About The Role Key responsibilities include: Contribute to the curriculum design, module development, and assessment strategy for the MSc Applied
-
. Fellowships provide a competitive salary and up to £30,000 in research expenses for 18–24 months, enabling fellows to establish a distinctive research programme and prepare competitive applications
-
members and 110 PhD students, and offers an exceptional multidisciplinary environment for cutting-edge cardiovascular and metabolic research. Learn more about our school (https://www.kcl.ac.uk/scms ) Our
-
Engineering & Imaging Sciences (BMEIS) and the Royal Brompton Hospital’s Imaging Department in Chelsea. The School of BMEIS (https://www.kcl.ac.uk/bmeis ) is committed to improving the way we deliver healthcare
-
Faculty of Natural, Mathematical and Engineering Sciences can be found at the following link: https://www.kcl.ac.uk/mathematics About you To be successful in this role, we are looking for candidates to have
-
, of which over 4500 were recruited to research. More information: https://www.kcl.ac.uk/bmeis About The Role This role provides an exciting opportunity for a dynamic and enthusiastic individual to join our
-
. This role will oversee a Phase 2/3 multi-arm, multi-stage (MAMS) trial evaluating the safety and efficacy of repurposed biosimilars and biologics in adults with epidermolysis bullosa (EB). https